AJOY

Ayujoy Herbals Ltd

AJOY, USA

Ayujoy Herbals Ltd., a research and testing organization, provides technical and regulatory consulting for biotechnical products, pharmaceuticals, diagnostics, medical equipment, and devices. The company serves various pharmaceutical companies in India and Southeast Asia to get FDA approval and facilitate exports of pharmaceuticals, and medical products and devices to the United States. Its services include analytical QC, QA functions, readiness for inspections, compliance, validation, clinical trial management, regulatory/legal, preparation of regulatory filings, compliance assessments, risk assessments, mock FDA audits, medical device support, CMC support, GMP training, facility layout consulting, and training, as well as utilities, process, IT, computer, and cleaning validation services. The company was incorporated in 2008 and is based in Mumbai, India.

https://www.groupeathena.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
AJOY
stock
AJOY

Titan Company Shareholders Approve Ajoy Chawla's Appointment as Managing Director scanx.trade

Read more →
AJOY
stock
AJOY

Titan Company Shareholders Approve Ajoy Chawla's Appointment as Managing Director Through Postal Ballot scanx.trade

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2023-12-31)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

0.04

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very Low

-3.52

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

133.17 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2,851.31 %

Low ≤ 2%

High ≥ 10%

Investors

* Institutions hold a combined 0.00% of the total shares of Ayujoy Herbals Ltd

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2023-12-31

EPS Actual

-0.0013

EPS Estimate

—

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2023-12-31)

Deep Value
Potential Value Candidate(3.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(2)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(0.5)
Quality
Low Quality Business(3)
Value
Undervalued(7)

Income Statement

(Last Updated 2023-12-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2023-12-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2023-12-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.